Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-05

FDA Approved: LEVETIRACETAM IN SODIUM CHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam in sodium chloride, a new injectable formulation by Hikma Pharmaceuticals USA Inc., expanding availabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam in Sodium Chloride (LEVETIRACETAM IN SODIUM CHLORIDE)

Snippet

SUPPL AP for LEVETIRACETAM IN SODIUM CHLORIDE (LEVETIRACETAM IN SODIUM CHLORIDE)